MPN-274 Avapritinib in Patients with Advanced Systemic Mastocytosis (advsm): Efficacy and Safety Analysis from the Phase 2 PATHFINDER Study with 3-Year Follow-up
Clinical Lymphoma Myeloma and Leukemia(2024)
关键词
MPN,systemic mastocytosis,tyrosine kinase inhibitor,c-kit
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要